Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Marea Therapeutics

Tracked across 1 events · 6 articles · First seen Sep 17, 2026 · Last active Sep 18, 2026

Sentiment
30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 30
Business
Lisata Therapeutics acquired Marea Therapeutics, a clinical-stage biotechnology company developing next-generation medicines for cardioendocrine diseases, in a stock-for-stock transaction. All of Marea's outstanding equity interests were exchanged for 1,793,129 shares of Lisata common stock and…
Impact: Target whose equity holders receive about 59.54% of the combined company, giving its cardioendocrine pipeline MAR001/005 and MAR002 a funded path to pivotal data.
Sep 17, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Marea Therapeutics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.